Preview

blue oceon strategy

Best Essays
Open Document
Open Document
2527 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
blue oceon strategy
Name:
Course:
Professor:
Date:
Blue Ocean strategy
Introduction
Blue ocean strategy is an argument fostered by authors on the way companies battled for success through competition. It was published in 2005, and it was based on more than 150 strategies used by more than a decade and thirty industries. Competition has been a key strategy to acquisition of larger market share among companies that produce similar products. The Blue ocean strategy represent analytical tools and frameworks that advances for the company’s ability to systematically capture and create Blue Ocean. The four principles of this strategy have the potential to influence the conventional strategies that various companies utilize. The four principles include the ability to reach beyond current existing demands, correct sequencing of strategies, expanding the focus picture and the means of creating uncontested market share. The market share can be created through restructuring the existing boundaries.
This paper seeks to analyze how blue ocean strategy has influenced the conventional strategies to expansion of the market share given that it makes the spirit of competition irrelevant to business. Furthermore, it seeks to discuss the authors view on blue ocean strategy if it is utopia or reality.

The challenged imposed by blue ocean strategy on conventional strategy models Every business that is established has a business model that guide the manner in which it carry out its operations. The model defines the manner in which the business will entice customers to purchase its goods. In addition, it guides the way the business managers will strategize the delivery of values to the customers. It can be deduced there are two universes that surround business that include red and Blue Ocean. The red ocean represents the market demand that the company has to battle in order to acquire a share. The boundaries of the companies are defined in the red ocean, and the company’s innovative abilities



References: Beck, Thorsten, Asli Demirgüç-Kunt, and Ouarda Merrouche. “Islamic vs. Conventional Banking: Business Model, Efficiency and Stability.” Journal of Banking & Finance 37.2 (2013): 433–447. ScienceDirect. Web. 14 Oct. 2014. Casadesus-Masanell, Ramon, and Joan Enric Ricart. “From Strategy to Business Models and onto Tactics.” Long Range Planning 43.2–3 (2010): 195–215. ScienceDirect. Web. 14 Oct. 2014. Business Models. Desyllas, Panos, and Mari Sako. “Profiting from Business Model Innovation: Evidence from Pay-As-You-Drive Auto Insurance.” Research Policy 42.1 (2013): 101–116. ScienceDirect. Web. 14 Oct. 2014. Harvad Business Review. “Blue Ocean Strategy.” Harvard Business Review. N.p., n.d. Web. 14 Oct. 2014. Kondoh, Shinsuke et al. “Toward a Sustainable Business Design: A Survey.” Procedia CIRP 15 (2014): 367–372. ScienceDirect. Web. 14 Oct. 2014. 21st CIRP Conference on Life Cycle Engineering. Lehoux, P. et al. “How Do Business Model and Health Technology Design Influence Each Other? Insights from a Longitudinal Case Study of Three Academic Spin-Offs.” Research Policy 43.6 (2014): 1025–1038. ScienceDirect. Web. 14 Oct. 2014. Li, Yan, and Chuan-Hoo Tan. “Matching Business Strategy and CIO Characteristics: The Impact on Organizational Performance.” Journal of Business Research 66.2 (2013): 248–259. ScienceDirect. Web. 14 Oct. 2014. Thought Leadership in Brand Management II. March-Chordà, I., and R. M. Yagüe-Perales. “Biopharma Business Models in Canada.” Drug Discovery Today 16.15–16 (2011): 654–658. ScienceDirect. Web. 14 Oct. 2014. Mittra, James, and Joyce Tait. “Analysing Stratified Medicine Business Models and Value Systems: Innovation-Regulation Interactions.” New Biotechnology 29.6 (2012): 709–719. ScienceDirect. Web. 14 Oct. 2014. Molecular Diagnostics & Personalised Medicine. Tiwana, Amrit. “Chapter 3 - Why Platform Businesses Are Unlike Product or Service Businesses.” Platform Ecosystems. Ed. Amrit Tiwana. Boston: Morgan Kaufmann, 2014. 49–59. ScienceDirect. Web. 14 Oct. 2014. Tongur, Stefan, and Mats Engwall. “The Business Model Dilemma of Technology Shifts.” Technovation 34.9 (2014): 525–535. ScienceDirect. Web. 14 Oct. 2014. Voelpel, Sven et al. “Escaping the Red Queen Effect in Competitive Strategy:: Sense-Testing Business Models.” European Management Journal 23.1 (2005): 37–49. ScienceDirect. Web. 14 Oct. 2014. Yunus, Muhammad, Bertrand Moingeon, and Laurence Lehmann-Ortega. “Building Social Business Models: Lessons from the Grameen Experience.” Long Range Planning 43.2–3 (2010): 308–325. ScienceDirect. Web. 14 Oct. 2014. Business Models.

You May Also Find These Documents Helpful

  • Powerful Essays

    [ 4 ]. Morgan, Steve, and Clare Mochrie. "Pharmaceutical Innovation: Can health and economic goals be met?" Centre for Health Services and Policy Research (July 2008): 1-9…

    • 1012 Words
    • 5 Pages
    Powerful Essays
  • Good Essays

    Have you ever wondered how a new product or service seems to appear from nowhere, then rises to the most sought after, must have in society? The term for an instance of this nature is referred as blue ocean. A description of this term comes from the notion that companies and organizations with similar products have boundaries that are defined and accepted by all competitors. These limitations lead to competition versus innovation, thus the term red ocean. According to Blue Ocean Strategy (2014), “red oceans refer to the known market space – all the industries in existence today. In red oceans, industry boundaries are clearly delineated and accepted, and the competitive rules of the game are known.” These boundaries and rules lead to companies battling to obtain the greatest share of the demand in their particular market, using subtle changes and a price difference to outshine their rivals. “Products turn into commodities, and increasing competition turns the water bloody” (Kim & Mauborgne, 2004).…

    • 777 Words
    • 3 Pages
    Good Essays
  • Good Essays

    According to Cham Kim and Renee Mauborgne (2004), the Blue Ocean strategy involves the description of how the organization should try and proceed to find some way to work in the marketplace that is not bloodied by the competition and also that is free of competitors. The strategy is against working in conditions such as Red Ocean, where businesses are ferociously fighting each other for some share of the marketplace. In essence, businesses are most often looking for ways that can better contend with their competitors, and that is the Blue Ocean strategy. According to the book Blue Ocean Strategy, the leading companies succeed not by battling with competitors, but by systematically developing “Blue Oceans” of uncontested market space ripe for the growth. Such a strategy of Blue Oceans the simultaneous pursuit of differentiation and also low cost, including the theory behind it not to outperform the competition in the on-hand industry, but to develop new market space or rather the “Blue Ocean”, in which case it makes the competition irrelevant. (Brooks, 2013) As such, the Blue Ocean strategy illustrates the opportunities of vast and untapped market spaces (Kim & Mauborgne, 2004)…

    • 957 Words
    • 3 Pages
    Good Essays
  • Best Essays

    Proj 587 Week 4

    • 4394 Words
    • 18 Pages

    Dess. (2012). Strategic Management text and cases, 6th Edition. McGraw-Hill Learning Solutions. Retrieved from <vbk:0077653017#outline(37.8.2)>.…

    • 4394 Words
    • 18 Pages
    Best Essays
  • Better Essays

    Lonsdale, C, (2013), “SP&SM Lectures Case Studies, Vodafone, Novartis, Rushmore University Hospital Trust” University of Birmingham Business School.…

    • 1803 Words
    • 8 Pages
    Better Essays
  • Powerful Essays

    Medisys Case Analysis

    • 1632 Words
    • 7 Pages

    The medical device manufacturing industry in 2009 was already competitive with future expectations of increased competition, when two deep pocketed, highly reputable public companies announced plans to launch additional product segments. Product development within the industry was both expensive and complicated. Firms were forced to meet strict quality and regulatory standards, sometimes including lengthy clinical trials, before final product distribution.…

    • 1632 Words
    • 7 Pages
    Powerful Essays
  • Satisfactory Essays

    Annotated Bibliography

    • 528 Words
    • 3 Pages

    Bert D. R. & Zeger Z. (2010) Business Strategy review, More Important Then Results 21(2), 81-83…

    • 528 Words
    • 3 Pages
    Satisfactory Essays
  • Better Essays

    Pharmanet-i3, a subsidiary of inVentive Health, is a world leading clinical research organization committed to the advancement of health around the world. The mission of Pharmanet-i3 is to be a strategic partner to companies that develop therapeutic drugs, and aim to bring drugs to the public that treat disease and improve the quality of life. The company will operate within the industry’s highest quality standards with uncompromising integrity, ethics, and respect for employees, study participants, the environment, and the communities in which the employees live and work. Shareholders can expect superior returns through the implementation of a successful growth strategy (Pharmanet-I3, n.d.).…

    • 1342 Words
    • 6 Pages
    Better Essays
  • Good Essays

    References: Adams, R. (2002). A good hard kick in the ass: Basic training for entrepreneurs. New York, NY: Random House/Crown Business Christensen, C.M. (1999). Innovation and the general manager. Boston, MA: McGraw-Hill Irwin Christensen, C.M. (2004). Eli Lilly and Company: Innovation in diabetes care. Boston, MA: Harvard Business School Publisher Gutierrez, C. (2007, October 18). Pfizer washes its hands of Exubera. Retrieved on May 27, 2012 from http://www.forbes.com/2007/10/18/pfizer-earnings-closer-marketsequities-cx_cg_1018markets47.html Lawsuit Guru (2008, Jun 27). FDA approves first inhaled insulin. Retrieved on May 28, 2012 from http://www.youtube.com/watch?v=gOy12-VIWI4 Simons, J. (2007, October 19). How the Exubera debacle hurts Pfizer. Retrieved od May 27, 2012 from http://money.cnn.com/2007/10/19/magazines/fortune/simons_ pfizer_erbitux.fortune/?postversion=2007101916 Weintraub, A. (2007, October 18). Pfizer´s Exubera Flop. Bloomberg BusinessWeek. Retrieved on May 26, 2012 from http://www.businessweek.com/technology/ content/oct2007/tc20071018_028695.htm…

    • 1248 Words
    • 5 Pages
    Good Essays
  • Powerful Essays

    Patients versus Profits at Johnson & Johnson: Has the Company Lost its Way?: Knowledge@Wharton ( http://knowledge.wharton.upenn.edu/article.cfm?articleid=2943)…

    • 2536 Words
    • 11 Pages
    Powerful Essays
  • Better Essays

    Eli Lilly

    • 1013 Words
    • 5 Pages

    For the solution of this problem, there are several options, as well as, constraints pertaining to the company. The main constraint of the company is specific treatment of its drugs. Less capital availability for clinical trials of drugs and time-consuming R&D process are the major restrictions. This problem can…

    • 1013 Words
    • 5 Pages
    Better Essays
  • Better Essays

    Cost Of Health Care

    • 1590 Words
    • 7 Pages

    Here in the United States, new medical technology is responsible for half of the growth in health care costs. As new and more effective medical procedures, drugs, and technologies are introduced into the market, the demand grows and more money is invested in them. The money is invested by the government, manufacturers, private investors, and in a minor scale by the health insurers. All the health care benefits and investments are the motivation for technological research and development to continue and accelerate in order to generate more profit (Fuchs & Garber:…

    • 1590 Words
    • 7 Pages
    Better Essays
  • Satisfactory Essays

    Bang Olufsen

    • 995 Words
    • 4 Pages

    “Technology and health-care companies compete on innovation. The key to their success is innovation and the ability to create the next valued product that consumers want, need, and are willing to purchase.” From the book…

    • 995 Words
    • 4 Pages
    Satisfactory Essays
  • Powerful Essays

    Iowh

    • 1592 Words
    • 7 Pages

    IOWH has an interesting model to circumvent the high R&D costs involved in pharmaceutical industry. Its business model is based on positioning IOWH as a credible potential company in the pharmaceutical industry to stimulate the inflow of funds from the prospective ‘donors’ and also to encourage other pharmaceutical and biotechnological companies to donate or share their valuable rights on their patent compounds which are not yet exploited fully. The functioning of the business model employs assembling an experienced and dedicated team of pharmaceutical scientists, identifying the promising compounds that could be developed into effective and affordable medicines and partnering with companies, hospitals and other organizations that share the same vision as that of IOWH and would help to advance IOWH towards its mission. IOWH also intends to partner with local manufacturing and distribution companies to ensure affordability and availability of the medicines to the patients in need. We identified the following key issues which are probably essential to sustain the business…

    • 1592 Words
    • 7 Pages
    Powerful Essays
  • Powerful Essays

    Biosimilar market in APAC

    • 1847 Words
    • 8 Pages

    The market sentiments towards biosimilars vary widely between the regulated and the semi- and unregulated markets. While regulated markets adopt an extremely cautious approach, the ‘pharmerging’ markets embrace the opportunity. Though ‘biobetters’ are often projected to have better future prospects over biosimilars, at least in the emerging markets the inclination is clearly towards biosimilars. The APAC region is particularly promising as a manufacturing hub as well as a market offering high potentials.…

    • 1847 Words
    • 8 Pages
    Powerful Essays